Hosted on MSN

CSL Limited Updates on Ongoing Share Buy-Back Program

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

CSL Reports Lapse of 34,261 Conditional Rights Under Equity Plan

CSL Limited has informed the market that 34,261 conditional rights (security code CSLAL) have lapsed after the performance or vesting conditions attached to them were not satisfied or became incapable ...
Nasdaq

JEFFERIES Maintains CSL Limited - Depositary Receipt (CSLLY) Buy Recommendation

Fintel reports that on December 8, 2025, JEFFERIES maintained coverage of CSL Limited - Depositary Receipt (OTCPK:CSLLY) with a Buy recommendation. As of December 6, 2025, the average one-year price ...
Business Insider

Jefferies Keeps Their Buy Rating on CSL (CMXHF)

Jefferies analyst David Stanton maintained a Buy rating on CSL (CMXHF – Research Report) on January 17 and set a price target of A$341.00. The company’s shares closed last Friday at $163.15. Discover ...
Hosted on MSN

CSL Limited Updates Share Buyback Program with New Broker Appointment

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from CSL ( (AU:CSL)) is ...
BioWorld

CSL to shave off 3,000 jobs, Seqirus vaccine unit

CSL Ltd.’s stock tumbled 16.88% on the news that it plans to cut 3,000 jobs and to hive off its Seqirus vaccine unit in a cost-cutting measure to save more than $500 million per year over the next ...